Pharmacokinetics of a phase I clinical trial of anti-angiogenic therapy - Relationship to pharmacodynamics by dynamic-MR and implications for future study design.

PJ Julyan, J Zweit, C Mulatero, J Lawrance, DL Hastings, A Jackson, H Haroon, D Levitt, T Tang, G Jayson

Research output: Contribution to journalArticlepeer-review

Cite this